Historical return extremes for Climb Bio (CLYM) from 2024 to 2026
What if you bought at the best or worst time? Max profit, max drawdown, and total return since IPO.
| Scenario | Return | Start date | Start price | End date | End price | $1,000 becomes |
|---|---|---|---|---|---|---|
| Max profitMore info about Max profit | +981.42% | $1.13 | $12.22 | $10,814.16 | ||
| Max drawdownMore info about Max drawdown | -86.64% | $8.46 | $1.13 | $133.57 | ||
| Return since IPOMore info about Return since IPO | +46.10% | $7.83 | $11.44 | $1,461.05 |
- Max profitMore info about Max profit+981.42%$10,814.16
- Max drawdownMore info about Max drawdown-86.64%$133.57
- Return since IPOMore info about Return since IPO+46.10%$1,461.05
Each row shows the start and end dates and prices for the scenario, the period return, and the resulting outcome for a $1,000 investment in Climb Bio (CLYM). Max profit is the best buy-and-sell pair across the entire price history; max drawdown is the worst peak-to-trough decline; the last row tracks return from IPO to today. Prices are split- and dividend-adjusted closing prices — actual outcomes would differ due to fees, taxes, and slippage.
Frequently asked questions
Data & methodology
Climb Bio (CLYM) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement